Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

32%

6 trials in Phase 3/4

Results Transparency

83%

15 of 18 completed trials have results

Key Signals

15 with results

Enrollment Performance

Analytics

Phase 1

6(31.6%)

Phase 2

4(21.1%)

Phase 3

4(21.1%)

Phase 4

2(10.5%)

N/A

2(10.5%)

Early Phase 1

1(5.3%)

19Total

Phase 1(6)

Phase 2(4)

Phase 3(4)

Phase 4(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT05955885Early Phase 1Completed

Effect of Over-the-counter NSAIDS on Cough Reflex Sensitivity in Patients with Upper Respiratory Tract Infections

Role: collaborator

NCT01075971Phase 2Completed

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)

Role: collaborator

NCT03642873Phase 1Completed

Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate

Role: lead

NCT03633448Phase 1Completed

Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents

Role: lead

NCT02181231Phase 1Completed

Buprenorphine Used With Treatment Resistant Depression in Older Adults

Role: collaborator

NCT03649750Phase 1Completed

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

Role: lead

NCT03725085Phase 4Completed

Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion

Role: lead

NCT03633487Phase 1Completed

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Role: lead

NCT01114581Phase 2Completed

Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection

Role: lead

NCT01229449Phase 3Completed

Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study

Role: lead

NCT02263248Phase 1Completed

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine

Role: collaborator

NCT01071538Phase 2Completed

Buprenorphine for Late-Life Treatment Resistant Depression

Role: collaborator

NCT01536834Not ApplicableCompleted

Safety & Performance Study of Verruca Treatment Device

Role: lead

NCT01986361Phase 3Completed

Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method

Role: lead

NCT01049334Phase 3Completed

A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis

Role: lead

NCT01048866Phase 3Completed

A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

Role: lead

NCT01619397Not ApplicableCompleted

Evaluation of Tolerance and Acceptability of a Coated Condom

Role: lead

NCT01537081Phase 2Completed

Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

Role: lead

NCT01257542Phase 4Terminated

Acute Cough Study In Children

Role: collaborator

All 19 trials loaded